Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Global Health Limited engages in the provision of healthcare services in India. The company primarily offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, musculoskeletal disorders and orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, plastic, aesthetic and reconstructive surgery, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, ayurveda, and dietetics and nutrition. It also offers lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, blood bank and e-ICU services, and health plans, as well as operates pharmacies. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in New Delhi, India.

Revenue projections:

Revenue projections for MEDANTA
Revenue projections for MEDANTA

MEDANTA's revenue is forecasted to dip below last year's figures, raising concerns for investors who are typically wary of declining financial performance. Such drops can directly affect the company's bottom line, potentially leading to a decrease in overall profitability, making investors more cautious in their decisions.

Financial Ratios:

currentRatio 2.399000
forwardPE 43.816933
debtToEquity 25.468000
earningsGrowth 0.209000
revenueGrowth 0.149000
grossMargins 0.513030
operatingMargins 0.164860
trailingEps 20.940000
forwardEps 23.410000

A current ratio of 2.399 for MEDANTA implies that the company has ample liquidity to meet its short-term debts. MEDANTA's cash reserves and current assets should easily cover these obligations, highlighting its financial stability and ability to manage short-term liabilities.
MEDANTA's low Debt-to-Equity ratio indicates the company is not over-leveraged. By limiting its dependence on debt, MEDANTA reduces its financial risk and demonstrates a strong capital structure, making it a more stable investment option for those wary of excessive borrowing.
Positive earnings and revenue growth for MEDANTA suggest that the company is expected to grow its business. This trend reflects strong financial performance, with continued profitability and sales increases indicating a bright outlook for future expansion.
With a forward EPS greater than its trailing EPS, MEDANTA is expected to see higher profitability this year. The forecasted increase in earnings reflects optimism about the company's financial growth and potential for improved performance over the prior year.

Price projections:

Price projections for MEDANTA
Price projections for MEDANTA

Over time, MEDANTA's price projections have been gradually lowered, signaling declining confidence in the company's future outlook. The downward revisions suggest analysts are becoming more cautious about MEDANTA's potential for growth.

Recommendation changes over time:

Recommendations trend for MEDANTA
Recommendations trend for MEDANTA


Analysts are favoring MEDANTA with a buy bias, highlighting the stock's potential as a solid investment. This recommendation might drive more investors to consider MEDANTA as a secure and profitable option for their money, contributing to a broader positive sentiment in the market.